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Abstract
The article by Van Herpe and colleagues in the previous issue of
Critical Care describes the glycemic penalty index (GPI), which
weights both hyperglycemic and hypoglycemic blood glucose
measurements commensurate to their clinically significant differ-
ence from target. Although certain adverse consequences result
from isolated severe hyperglycemic episodes, several specific out-
comes depend upon overall hyperglycemia. In contrast, although
mortality has been related epidemiologically to overall low blood
glucose, specific negative outcomes may depend upon isolated
episodes. Capturing both hypoglycemia and hyperglycemia in a
single index will be shown to be useful if the GPI enables us to
better define insulin strategies, outcomes, and targets.
In the previous issue of Critical Care, Van Herpe and
colleagues describe a new method of blood glucose
reporting for hospitalized patients, the glycemic penalty index
(GPI) [1]. A stepped scale weights the clinical significance of
differences of blood glucose (BG) from target. The GPI scale
is appropriately accordioned on the hypoglycemic range and
expanded on the hyperglycemic range. The relative contribu-
tions of hypoglycemia and hyperglycemia to the index may be
stated separately. The authors recommend that use of the
index should be combined with counting of episodes of
severe hypoglycemia. The index, capturing both overall hyper-
glycemia and hypoglycemia, could permit analysis of the ability
of an algorithm to control between-patient glycemic variability.
In the evaluation of glycemic control, the measures that are
simplest to ascertain are the average and standard deviation,
using the BG as the unit of observation [2]. In the Leuven,
Belgium surgical intensive care unit, the standard deviations
in intensively and conventionally treated groups was 19 and
33 mg/dL, respectively [2]. It could have been asked whether
the greater BG variability in the conventionally treated group
reflected the contribution of a hyperglycemic subgroup. Until
a second report was issued referring to control at the patient
level, within the conventionally treated group even the
relationship between hyperglycemia and mortality rate was
unclear [3].
In order to evaluate patient outcomes, there is no substitute
for reporting on the patient as the unit of observation. A key
question is whether patient outcomes relate to overall
hyperglycemia during a critical timeframe or to specific
episodes of severe hyperglycemia. The answer, predicated
upon the mechanism of harm, could depend upon what
outcome is being studied. Single episodes of severe hyper-
glycemia, such as the in-hospital development of diabetic
ketoacidosis or hyperglycemia-associated dehydration, may
result in specific consequences, such as dialysis fistula
thrombosis, readmission to a critical care unit, or treatment-
related pulmonary edema. The association of single episodes
with outcomes was recognized by Stagnaro-Green and
colleagues [4]. Furnary and colleagues [5], capitalizing upon
a critical window of time in the postoperative interval
following heart surgery, have reported on outcomes in
relation to the “3-day BG,” each value representing a
patient’s 3-day average of postoperative BG measurements
[5]. Recent literature supports the importance of overall
prevention of hyperglycemia, at least during critical windows
of time, with respect to survival and morbidities such as
sepsis, renal failure, duration of ventilator dependency, or
transfusion requirement [2,6]. Unfortunately, we have no
simple measure comparable to the A1C by which the short-
term inpatient overall glycemic control of an individual may be
described.
Although hypoglycemia might simply reflect severity of
comorbidities, the correlation between hypoglycemia and
mortality of hospitalized patients is well known [7]. Evidence
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from a mixed intensive care unit suggests that hypoglycemia
is an independent predictor of mortality [8]. Among groups of
patients having myocardial infarction or congestive heart
failure, observational patient-level data suggest that when
mortality is considered as a function of overall BG
concentration, there may be a J-shaped curve, such that
patients having the lowest and the highest averages
experience outcomes worse than those having intermediate
range BG control [9,10]. Is there a plausible mechanism by
which modest overall reduction of average BG might cause
harm, and if so, what specific harm is caused? Alternatively, is
harm a consequence of isolated episodes of severe
hypoglycemia, to which the population having lower average
BG is more vulnerable?
In the literature concerning strict glycemic control, serious or
fatal consequences of hypoglycemia occasionally are
reported [11,12]. However, even when severe hypoglycemia
is reported, sublethal permanent neurological injury seldom is
described [13,14]. If a patient-level metric relied only upon
BG averaging methods, isolated episodes of severe
hypoglycemia could be overlooked that had resulted in
altered function with respect to the activities of daily living or
reduction of intellectual capacity. A superior method of
ascertainment is to count such episodes and describe their
consequences [15].
Application of the GPI index is cumbersome, such that other
centers may have difficulty in adopting the method; therefore,
the measure may remain unfamiliar. Perhaps overall
hyperglycemia and discrete episodes of hypoglycemia ought
not to be captured by the same metric. An extra mental step
is needed to quantify the contribution of hypoglycemia and
hyperglycemia as a fraction of the total value of the index. The
mathematical strategy of the GPI avoids overemphasis on
outlying results. Multiple small episodes of hypoglycemia,
none having clinical impact, might be weighted equally to one
severe life-changing episode. Analysis of episodes of severe
hypoglycemia should complement the use of the GPI, as the
authors acknowledge. With that caveat, can a single measure
sum up patient risk for a variety of outcomes that might be
related to glycemic control? We await evidence that the GPI
will improve upon our ability to define glycemic targets and
predict clinical outcomes.
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